Method Peptides · Research compound

Ipamorelin

$300.00
Dose
≥99% purity
Third-party tested
Ships from the USA
Secure, discreet packaging
ShippingFree on orders $200+

$15 flat rate on orders under $200.

FulfillmentMade to order

Allow 7–10 business days before shipment.

Review return policy →

Research reference

Compound overview

Product specifications, research context, and handling information.

Ipamorelin

Ipamorelin is a synthetic pentapeptide studied as a growth hormone secretagogue and ghrelin-receptor agonist.

Research models examine GHS-R1a signaling, pituitary responses, growth hormone release, and differences among secretagogue compounds. This listing is supplied as a kit of 10 vials, with per-vial amounts shown in Product Details.

Key Research Areas

  • Ghrelin-receptor pharmacology
  • Pituitary-response models
  • Growth hormone signaling
  • Secretagogue comparison studies

Mechanism of Interest

Ipamorelin engages the ghrelin receptor, GHS-R1a, which participates in growth hormone release. Selectivity reported in experimental studies is model-dependent and does not establish a product safety profile.

Product Details

Format: Kit of 10 vials
Available Options: 5 mg per vial × 10 vials = 50 mg per kit; 10 mg per vial × 10 vials = 100 mg per kit
Compound Class: Synthetic pentapeptide; growth hormone secretagogue
Compound: Ipamorelin
Storage: Follow the product label and lot-specific storage instructions. Prepared-sample storage depends on formulation and validated laboratory stability conditions.

Ghrelin Receptors and GH Release

Ipamorelin research examines how ghrelin-receptor activation relates to growth hormone release. Comparisons with other secretagogues help characterize receptor responses and the resulting patterns of endocrine activity.

Research Use Only:

This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.